Approximately 40% of all PGLs are associated with SDH deficiency (Gill et al. 2010a), and those associated with SDHB mutations (PGL4) are at higher risk of malignancy (Timmers et al. 2007). The gene discussed is SDHB; the disease is hyperinsulinemic hypoglycemia, familial, 4.